Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia

NCT04533724 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04533724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia
Lead sponsor
Shanghai Mental Health Center
Phase
Phase 1
Overall status
Unknown status
Start date
October 1, 2020
Completion date
September 30, 2022
Enrollment
6 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

amisulpride, gut microbiomes, negative symptom, schizophrenia